Researchers from the Karolinska Institutet in Stockholm, Sweden, have published a population-based cohort study examining the risks of autism, ADHD or intellectual disability following paracetamol […]
Welcome
ENTIS is a global collaborative network of Teratology Information Services. Member organisations consist of medical doctors, pharmacists, genetic counsellors and scientists all working together with the primary aim of preventing birth defects and developmental disorders which arise as a consequence of maternal or paternal perinatal exposures.
ENTIS member organisations work in three core areas:
ENTIS collaborates with researchers from a range of academic, industry and patient representative organisations. If you are interested in working with ENTIS or in joining our network, please contact us.
Alternatively, click here to learn more about ENTIS.
Latest Annual Conference News
Latest Teratology Studies
Paternal glatiramer acetate use not associated with increased risks of adverse pregnancy or fetal outcomes
Researchers from TEVA pharmaceuticals have published a small case series describing 232 prospective cases of paternal glatiramer acetate use, and the associated pregnancy and fetal […]
ENTIS-OTIS 2024: Registration now open
Registration details here
Safety data for fibrate use in pregnancy published
Researchers from Seoul National University (Republic of Korea) have published a nationwide retrospective cohort study using data from the Korean National Health Insurance database investigating […]
ENTIS-OTIS 2024 conference website launched
The organisers of the 2024 ENTIS-OTIS conference, being held in Nyborg, Denmark (September 12-15th, 2024), have launched the conference website.
Study finds no increased risk of autism spectrum disorder with maternal topiramate use in pregnancy
A large population-based cohort study using data from US healthcare utilisation databases (Medicaid and MarketScan) suggests that topiramate use in pregnancy may not be associated […]
Medication use in pregnancy on the rise
Researchers from Aarhus University (Denmark) have published an analysis of population-level prescribing data which provides evidence of the rising prevalence of medication use in pregnancy. […]
Live births following leflunomide exposure and malformation risks
Researchers from the University of Bremen have published data from the German Pharmacoepidemiological Research Database describing the outcomes of 205 pregnancies where leflunomide dispensing overlapped […]